Sectra AB Company Overview and Updates

Sectra AB is a leading global provider of enterprise image management solutions.

Founded in 1978, Sectra has over 40 years of experience in developing and delivering medical imaging and cybersecurity solutions.

Headquartered in Linköping, Sweden, Sectra has a strong presence in the European market.

The company has a diverse portfolio of products and services that cater to various industries, including healthcare and defense.

Sectra AB has expanded its orthopedic solution with 3D templates from Smith+Nephew.

The company has also reported strong surge in orders and rising operating profit in its Q1 2026 earnings call.

Sectra AB's earnings results for the first quarter ended July 31, 2025, showed a Q1 EBIT of SEK 118.8 million.

The company has approved extra and ordinary dividends, payable on September 16, 2025.

Sectra AB's stock price has fluctuated over the years, with a current price of 377.4, compared to 19.3 in 10 years ago.

Here's a breakdown of Sectra AB's stock price over the years:

Sectra AB has also partnered with University Medical Center in Germany to expand the use of its solution with AI service, accelerating the adoption of AI for enhanced efficiency and patient care.

Meet the team behind Sectra AB's success. Clas Harald Torbjörn Kronander is the CEO, a position he's held since October 31, 2012.

The company's Director of Finance/CFO is Jessica Holmquist, who took on the role on March 19, 2022.

Per Andersnäs is the Chief Tech/Sci/R&D Officer, a position he's held since December 31, 1996.

Here are the key members of Sectra AB's management team:

Jan-Olof Vilhelm Arn Brüer is the Chairman, a position he's held since September 5, 2018.

Clas Harald Torbjörn Kronander and Anders Persson are both Director/Board Members, with Kronander holding the position since December 31, 1984, and Persson since December 31, 2003.

Sectra AB's share price has seen significant fluctuations over the past year, with a 52 Week High of SEK 377.40 and a 52 Week Low of SEK 220.00.

The current share price is SEK 309.60, which is a 1 Month Change of -0.51% and a 3 Month Change of -16.41%. The 1 Year Change is 8.71%, indicating a modest increase.

Here are the key share price changes over the past few years:

The company's performance is also reflected in its Beta, which is 1.34, indicating a slightly higher level of volatility compared to the market.

Analysts have been weighing in on Sectra AB's performance, with varying recommendations. SEB Lowers Target Price for Sectra to SEK 335 (355), Reiterates Hold.

DNB Carnegie has raised its target price for Sectra multiple times, most recently to SEK 300 (285) on June 9. They've also reiterated a hold recommendation.

On the other hand, Affärsvärlden has renewed its sell recommendation for Sectra, citing the company's high valuation.

Here's a summary of the analysts' recommendations:

SEB Bank Boosted Sectra's target price, affirming a hold rating on May 30.

Sectra (SECT B) is a company that provides solutions for medical IT and cybersecurity sectors in Sweden, the United Kingdom, the Netherlands, and the rest of Europe.

Their earnings are forecast to grow 17.15% per year, which is a significant increase.

The company has experienced a 7-day return of 5.7%, outperforming the market.

Over the past year, their return has been 8.7%, which is a notable improvement.

Here's a comparison of their performance with the industry and market:

It's worth noting that while their return has been strong, they underperformed the Swedish Healthcare Services industry over the past year, returning 10.5% compared to their 8.7%.

The price performance of a stock can be a crucial factor in determining its overall health and potential for growth.

The current share price of Sectra is SEK 309.60, which is a significant increase from its 52 Week Low of SEK 220.00.

Over the past year, the stock has shown a positive trend, with a 1 Year Change of 8.71%. This is a promising sign for investors.

Broaden your view: Traton Stock

However, the stock has experienced some volatility in the short term, with a 1 Month Change of -0.51% and a 3 Month Change of -16.41%.

Despite this, the stock's long-term performance is impressive, with a 5 Year Change of 185.08% and a Change since IPO of 10,957.16%.

Here's a summary of the stock's price performance over different time periods:

Sectra AB is a company that offers a range of medical technology and services. Its products include MSK Radiology, Ophthalmology Imaging, and Sectra 2D Planning System.

Sectra's services include Integration Services, Installation Services, and Security Administration. The company partners with other healthcare providers to deliver its solutions, such as a partnership with a medical center in the US to provide its enterprise imaging cloud service.

Some of Sectra's notable achievements include expanding its orthopedic solution with 3D templates from Smith+Nephew and being awarded a contract to install four MicroDose Mammography units in Victoria, Australia.

The medical technology industry is growing rapidly, with a projected global market size of $1.5 trillion by 2025, up from $600 billion in 2020.

Medical imaging technologies, such as MRI and CT scans, have become essential tools in modern medicine.

The use of telemedicine has increased significantly, with 46% of healthcare organizations offering virtual consultations in 2020.

Electronic health records (EHRs) have improved patient care by allowing for seamless data sharing and access to medical history.

The use of artificial intelligence (AI) in medical diagnosis has shown promising results, with AI-powered systems achieving a 95% accuracy rate in detecting breast cancer.

The demand for medical devices is expected to increase by 10% annually, driven by the growing need for diagnostic equipment and implantable devices.

You might enjoy: Mercator Medical

Understanding ICT spending is crucial for any business, and in the medical technology sector, it's no exception. IT Client Prospector provides intelligence on Sectra AB's likely spend across technology areas, enabling you to understand the digital strategy.

This information can be a game-changer for companies looking to invest in medical technology. By analyzing Sectra AB's ICT spend, businesses can make informed decisions about their own investments.

The digital strategy of Sectra AB is a key area of focus for their ICT spend. IT Client Prospector provides valuable insights into this area, helping businesses make informed decisions.

Companies can use this information to adjust their own ICT spend and priorities, aligning them with the latest trends and technologies. This can lead to improved efficiency and effectiveness in their operations.

By understanding Sectra AB's ICT spend and priorities, businesses can gain a competitive edge in the medical technology sector. This is especially important in a field where staying up-to-date with the latest technologies is crucial.

Consider reading: Companies like Palantir and Anduril

Medical Tech Services is a rapidly evolving field, and Sectra AB is a key player in this space. With a market capitalization of 6.31 billion dollars, Sectra AB offers a range of medical software and technology services.

Curious to learn more? Check out: Tata Consultancy Services

The company has made significant strides in recent years, with a 4.45% increase in stock value over the past 5 days. This growth is a testament to the company's commitment to innovation and customer satisfaction.

Sectra AB's products and services include MSK Radiology, Ophthalmology Imaging, and Sectra 2D Planning System, among others. These solutions are designed to improve patient outcomes and enhance the overall healthcare experience.

According to the company's financial reports, Sectra AB has a weighted average market capitalization of 8.29 billion dollars. This significant market presence allows the company to invest in research and development, driving innovation in the medical tech space.

Here are some key statistics about Sectra AB's competitors:

Sectra AB's commitment to innovation and customer satisfaction has earned the company a reputation as a leader in the medical tech space.

Sectra is expanding its orthopedic solution with 3D templates from Smith+Nephew, a move that's expected to improve surgical planning and execution. This technology has the potential to make a real difference in patient outcomes.

Sectra has also made headlines with its photon counting technology, which is being hailed as a game-changer in breast imaging. This technology is being used to improve data management and display, making it easier for radiologists to diagnose breast cancer.

One hospital that's already benefiting from Sectra's technology is Altötting hospital, where radiologist Dr. Christoph Seifried and his team are using the Sectra workstation IDS7/rx to speed up diagnosis.

Sectra has also taken its place in the medical technology market with a new workstation, IDS7/rx. This workstation is designed to improve the efficiency of radiologists and their teams.

Here are some key features of Sectra's technology:

Örebro University has invested in virtual medical technology to offer the most modern medicine program in Sweden, which is a great example of how medical technology is being used to improve healthcare.

This investment includes visualization tables from Sectra, a company that specializes in medical technology.

Sectra has partnered with Unilabs, a private care provider in Sweden, to offer preventive bone health testing for individuals with risk factors for osteoporosis.

This service is available starting immediately and is a great step forward in enabling individuals to take measures to protect their bone health.

Here are some key points about Sectra's medical technology:

Sectra, a Swedish IT and medical-technology company, has been focusing on enhancing customer productivity. They achieved this by launching Sectra PACS release 12.1 with RapidConnect technology.

This launch marked the start of the third phase in the rollout of Sectra's product. The company is committed to helping its customers achieve their goals.

The introduction of RapidConnect technology is a significant step forward in improving customer productivity. It enables users to access medical images and data more efficiently.

Sectra's focus on customer productivity is a testament to the company's dedication to meeting the needs of its clients. By doing so, they aim to make a positive impact on the medical industry.

Sectra AB has established partnerships and collaborations with various companies to expand its reach and capabilities.

Sectra has entered into a cooperation with Visiopharm A/S for open systems in medical imaging. This collaboration enables the exchange of pathology images between their respective digital pathology systems.

In addition to this, Sectra has also partnered with Edo Med Sp.z o.o. to distribute its medical systems in Poland. This partnership is a significant step for Sectra's growth in the radiology and oncology market.

Sectra has also expanded its imaging solution to include digital pathology with the Dutch hospital Zuyderland MC. This partnership enables the hospital to access and share pathology images more efficiently.

Here are some of Sectra's notable partnerships and collaborations:

Sectra and Visiopharm A/S have partnered on an open exchange of pathology images between their respective digital pathology systems.

This cooperation aims to facilitate the integration of pathology images across different systems, enabling seamless collaboration and data sharing among healthcare professionals.

The partnership involves an open exchange of pathology images, which is a significant step forward in the field of digital pathology.

The companies involved in this partnership are Sectra and Visiopharm A/S, both experts in their respective fields.

The partnership has the potential to improve the efficiency and accuracy of pathology diagnosis, which can lead to better patient outcomes.

Here are the key areas of cooperation between Sectra and Visiopharm A/S:

Vital Images and Sectra have deepened their relationship by expanding their partnership. This move aims to enhance their cooperation in the field of medical technology.

Their expanded partnership involves the use of Sectra's PACS (Picture Archiving and Communication System) technology. This system is designed to improve data management, security, and workflow efficiency.

This partnership is a significant development in the medical technology industry. It demonstrates the importance of collaboration and cooperation in driving innovation and improvement.

The benefits of this partnership are numerous, including improved data management, enhanced security, and streamlined workflow. These improvements will ultimately lead to better patient care and outcomes.

Here are some key areas where Vital Images and Sectra are collaborating:

Sectra AB is a leader in digital health initiatives, particularly in the field of digital pathology. They have a strong presence in the Nordic region, with contracts signed with healthcare regions in Norway, Sweden, and the Netherlands.

Their solutions enable pathologists to review and share digital pathology images, making it easier to diagnose and treat diseases. For example, University Hospital Utrecht in the Netherlands has invested in a solution from Sectra for storing, viewing, and sharing digital pathology images.

Sectra's digital pathology solutions are integrated with existing enterprise imaging solutions, such as the one used by the Norwegian healthcare region Helse Vest RHF. This integration enables seamless sharing and storage of digital pathology images, improving workflow efficiency.

Here are some of the key digital health initiatives undertaken by Sectra AB:

The Swedish region of Region Östergötland is making a full commitment to digital pathology by investing in a solution from Sectra for storage, review, and sharing of digital pathology images.

Related reading: Digital Equipment Corporation

This investment is a significant step towards modernizing healthcare in the region. Sectra's digital pathology solution will enable pathologists to review and analyze digital pathology images more efficiently.

The Region Östergötland is not the only Swedish region to invest in digital pathology. Helse Vest RHF, another Norwegian healthcare region, has also signed a digital pathology contract with Sectra.

Here are some key facts about Sectra's digital pathology solutions:

By investing in digital pathology, the Region Östergötland is joining the ranks of other pioneering healthcare regions in Norway and the Netherlands. University Hospital Utrecht in the Netherlands, for example, has invested in a solution from Sectra for storing, viewing, and sharing digital pathology images.

This trend towards digital pathology is likely to continue, as more healthcare regions recognize the benefits of modernizing their pathology services.

Additional reading: Digital Realty

In the Netherlands, a Dutch university hospital has been a pioneer in digital pathology, investing in a solution from Sectra to store, view, and share digital pathology images. This solution enables pathologists to review images more efficiently.

University Hospital Utrecht (UMCU) was the first to implement this solution, making it a leader in digital pathology. The solution allows pathologists to access and share digital images, improving collaboration and diagnosis.

The hospital's decision to adopt digital pathology has set a precedent for other hospitals in the Netherlands. Sectra's solution has been well-received, enabling pathologists to work more efficiently.

Sectra's solution has also been expanded to include digital pathology at Zuyderland MC, another Dutch hospital. This expansion highlights the growing demand for digital pathology solutions in the Netherlands.

Here are some key hospitals in the Netherlands that have invested in digital pathology solutions from Sectra:

Digital pathology is revolutionizing the way medical images are stored, viewed, and shared. Sectra, a leading medical imaging IT and cybersecurity company, has signed a digital pathology contract with Helse Vest RHF in Norway.

The Norwegian healthcare region already uses Sectra's existing enterprise imaging solution. This integration will further enhance their digital pathology capabilities.

University Hospital Utrecht in the Netherlands is a pioneer in digital pathology, having invested in a solution from Sectra. This solution enables pathologists to review and share digital pathology images efficiently.

Digital pathology is not just about technology, but also about streamlining workflows. By digitizing pathology, medical professionals can focus on what matters most – patient care.

Sectra's radiology IT solution has been chosen by VUmc University Hospital of Amsterdam, which performs a significant number of radiology examinations annually. This partnership will help improve the handling of medical images.

Sectra has been awarded a significant grant from the European Union to lead a research project focused on reducing breast cancer mortality. This project brings together clinical and industrial partners from six European countries.

Here are some key players in the digital pathology space:

Sectra AB is a company that specializes in medical imaging IT and cybersecurity solutions. They have a range of products and services that cater to the needs of healthcare professionals.

Their PACS (Picture Archiving and Communication System) solutions enable efficient management of medical imaging across departments and the entire enterprise. This includes radiology, mammography, and pathology images.

Sectra's PACS solutions are built on their proprietary RapidConnect technology, which allows for fast and secure transfer of large image stacks over strained networks. This technology has been showcased at various conferences, including the European Congress of Radiology (ECR).

Some of the key features of Sectra's PACS solutions include:

* Support for mammography and breast imagingIntegration with RIS (Radiology Information System) systemsAbility to handle large image stacks and strained networksSecure and fast transfer of images

Sectra's solutions have been adopted by various healthcare institutions, including university hospitals and healthcare regions. For example, the Swedish healthcare region Region Östergötland has invested in Sectra's digital pathology solution for storage, review, and sharing of digital pathology images.

Sectra has been actively involved in the field of mammography and breast cancer research. The company has successfully tested the display of breast tomo images at the North American IHE Connectathon in Cleveland.

Sectra has also partnered with Royal Philips Electronics to acquire its mammography modality operations for EUR 57.5 million. This deal is expected to have a significant impact on the company's offerings in the field of mammography.

The company has also been awarded a contract to install four MicroDose Mammography units in Victoria, Australia. These units offer improved imaging capabilities for breast cancer screening.

Here are some key statistics related to Sectra's involvement in mammography and breast cancer research:

Sectra has made significant advancements in mammography technology, particularly with the launch of their next-generation mammography workstation at RSNA 2009 in Chicago.

This workstation is built on Sectra's RapidConnect technology, which focuses on customer productivity. It's designed to improve efficiency and streamline workflows in breast imaging departments.

With this new workstation, Sectra aims to increase productivity and improve patient care. This is a crucial step in the fight against breast cancer.

Here are some of the key features of Sectra's next-generation mammography workstation:

Sectra's commitment to innovation and customer satisfaction is evident in their continued development of advanced mammography solutions.

Breast cancer screening programmes are helping to reduce the mortality rates of women by finding cancer in its early stages when it is easier to treat. Sweden was one of the first countries in the world to implement a national breast cancer screening programme.

Mammography is a crucial tool in breast cancer screening, and it's essential to ensure that the dose levels are accurate and safe. A survey of dose levels in mammography in Swedish clinical practice is a great step towards achieving this goal.

Research shows that breast cancer screening programmes are effective in reducing mortality rates. In fact, a survey of dose levels in mammography in Swedish clinical practice suggests that these programmes are helping to reduce the mortality rates of women.

Here's a summary of the key findings from the survey:

Sectra AB has been making waves in the medical imaging IT and cybersecurity space with its innovative product launches and updates.

The company launched a vendor-neutral integration for machine learning applications, allowing customers to utilize machine learning in their enterprise imaging platform. This integration is a game-changer for the industry, enabling seamless access to machine learning capabilities.

Sectra has also rolled out a solution for efficient management of all medical imaging across departments throughout the entire enterprise. This solution is designed to handle large image stacks over strained networks, making it a valuable asset for hospitals and imaging centers.

At RSNA 2009, Sectra launched a new breast imaging PACS workstation built on Sectra RapidConnect technology. This next-generation mammography workstation focuses on customer productivity and is a testament to the company's commitment to innovation.

Sectra's RIS/PACS platform enables workload sharing across multiple sites, making it an ideal solution for large-scale imaging operations. This feature is particularly useful for hospitals with multiple locations or for imaging centers that need to share resources.

Here are some key product launches and updates from Sectra AB:

Sectra AB has been expanding its partnerships and presence in the medical technology industry. The company has signed a digital pathology contract with the Dutch hospital Zuyderland MC, allowing for a digital pathology workflow.

Sectra has also reached an agreement with digital pathology company Visiopharm A/S on an open exchange of pathology images between their respective digital pathology systems. This cooperation aims to improve data sharing and collaboration.

In addition to its partnerships, Sectra has been expanding its presence in various markets. The company has signed a distribution agreement with the Greek company Proton S.A., a provider of medical imaging and security systems based in Athens.

Sectra's partnerships have also led to the expansion of its PACS (Picture Archiving and Communication System) capabilities. The company has deepened its relationship with Vital Images, a leading provider of advanced visualization and analysis software, to improve data management, security, and workflow.

Here's a summary of Sectra's partnerships and expansions:

Sectra AB has a strong track record of financial performance, with a revenue increase of 24% in the first quarter.

The company's operating profit margin improved to 13.8% for Q1, exceeding its core financial targets.

Sectra's revenue model is based on long-term contracts and service agreements with hospitals and healthcare facilities worldwide, ensuring a steady stream of repeat business.

Recurring revenue as a whole rose 21% and now makes up 67% of total sales, with churn remaining extremely low at 0.4%.

Cloud recurring revenue grew 42% and now reaches SEK 123 million, a significant milestone in the company's shift to cloud-based service sales.

Sectra's diversified income stream, which includes government and defense agencies, allows the company to remain resilient against the cyclicality of single-market dependencies.

The company is investing heavily in the shift to cloud, which will weigh on profits for the rest of the year.

For another approach, see: Trican Well Service